Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...

For patients with high-grade carotid stenosis without recent symptoms, the addition of stenting is associated with a reduced risk for a composite of perioperative stroke or death or ipsilateral stroke ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

Discover why American Healthcare REIT is the top pick for senior housing investment, with strong fundamentals and promising returns.

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

Orca-T immunotherapy shows promising results in improving survival and reducing complications in patients with hematologic ...

CEO and managing director Dr Kilian Kelly has reflected on what he described has been a "transitional year" for the stem cell ...

Kraig Biocraft Laboratories set a distinctive tone with a detailed Christmas shareholder letter that framed 2025 as the company’s inflection year, marking its transition from prolonged development ...

We may learn more about Jeffrey Epstein's dealings with Les Wexner, the 88-year-old billionaire whose money and influence ...

Check out our full preview and tips for Eagle Farm. Minimal rain and if anything like the last meeting here, track records ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global ...